tetano
Editor, Senior Moderator
J Med Virol
. 2021 Jan 15.
doi: 10.1002/jmv.26797. Online ahead of print.
Association between Red Blood Cell Distribution Width and Mortality and Severity among Patients with COVID-19: A Systematic Review and Meta-Analysis
Jane J Lee[SUP] 1 [/SUP], Sahar Memar Montazerin[SUP] 2 [/SUP], Adeel Jamil[SUP] 3 [/SUP], Umer Jamil[SUP] 3 [/SUP], Jolanta Marszalek[SUP] 4 [/SUP], Michael L Chuang[SUP] 2 [/SUP], Gerald Chi[SUP] 2 [/SUP]
Affiliations
Abstract
Emerging evidence has underscored the potential usefulness of red blood cell distribution width (RDW) measurement in predicting the mortality and disease severity of COVID-19. This study aimed to assess the association of the plasma RDW levels with adverse prognosis in COVID-19 patients. A comprehensive literature search from inception to September 2020 was performed to harvest original studies reporting RDW on admission and clinical outcomes among patients hospitalized with COVID-19. RDW levels were compared between cases (patients who died or developed more severe symptoms) and controls (patients who survived or developed less severe symptoms). A total of 14,866 subjects from 10 studies were included in the meta-analysis. Higher levels of RDW were associated with adverse outcomes in COVID-19 patients (mean differences=0.72; 95% CI=.47-0.97; I[SUP]2[/SUP] =89.51%). Deceased patients had higher levels of RDW compared to survived patients (mean differences=0.93; 95% CI=0.63-1.23; I[SUP]2[/SUP] =85.58%). Severely ill COVID-19 patients showed higher levels of RDW, as opposed to patients classified to have milder symptoms (mean differences=0.61; 95% CI=0.28-0.94; I[SUP]2[/SUP] =82.18%). Elevated RDW levels were associated with adverse outcomes in COVID-19 patients. This finding warrants further research on whether RDW could be utilized as a simple and reliable biomarker for predicting COVID-19 severity and whether RDW is mechanistically linked with COVID-19 pathophysiology. This article is protected by copyright. All rights reserved.
Keywords: COVID-19; biomarkers; erythrocyte indices; red blood cell distribution width; severe acute respiratory syndrome coronavirus 2.
. 2021 Jan 15.
doi: 10.1002/jmv.26797. Online ahead of print.
Association between Red Blood Cell Distribution Width and Mortality and Severity among Patients with COVID-19: A Systematic Review and Meta-Analysis
Jane J Lee[SUP] 1 [/SUP], Sahar Memar Montazerin[SUP] 2 [/SUP], Adeel Jamil[SUP] 3 [/SUP], Umer Jamil[SUP] 3 [/SUP], Jolanta Marszalek[SUP] 4 [/SUP], Michael L Chuang[SUP] 2 [/SUP], Gerald Chi[SUP] 2 [/SUP]
Affiliations
- PMID: 33448439
- DOI: 10.1002/jmv.26797
Abstract
Emerging evidence has underscored the potential usefulness of red blood cell distribution width (RDW) measurement in predicting the mortality and disease severity of COVID-19. This study aimed to assess the association of the plasma RDW levels with adverse prognosis in COVID-19 patients. A comprehensive literature search from inception to September 2020 was performed to harvest original studies reporting RDW on admission and clinical outcomes among patients hospitalized with COVID-19. RDW levels were compared between cases (patients who died or developed more severe symptoms) and controls (patients who survived or developed less severe symptoms). A total of 14,866 subjects from 10 studies were included in the meta-analysis. Higher levels of RDW were associated with adverse outcomes in COVID-19 patients (mean differences=0.72; 95% CI=.47-0.97; I[SUP]2[/SUP] =89.51%). Deceased patients had higher levels of RDW compared to survived patients (mean differences=0.93; 95% CI=0.63-1.23; I[SUP]2[/SUP] =85.58%). Severely ill COVID-19 patients showed higher levels of RDW, as opposed to patients classified to have milder symptoms (mean differences=0.61; 95% CI=0.28-0.94; I[SUP]2[/SUP] =82.18%). Elevated RDW levels were associated with adverse outcomes in COVID-19 patients. This finding warrants further research on whether RDW could be utilized as a simple and reliable biomarker for predicting COVID-19 severity and whether RDW is mechanistically linked with COVID-19 pathophysiology. This article is protected by copyright. All rights reserved.
Keywords: COVID-19; biomarkers; erythrocyte indices; red blood cell distribution width; severe acute respiratory syndrome coronavirus 2.